Merck’s Cidara Therapeutics acquisition brings a lead program with potential to become a first-in-class drug for preventing influenza infection. A Phase 3 study is already underway, timed to coincide with the start of the flu season in the Northern Hemisphere. The post Merck Makes Big Antiviral M... Read more
Medcity News - Nov 14
Respiratory viral diseases pose severe threats to animal health and global food security, especially in intensive pig farming systems. Read more
Medical News - Oct 11
